Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV.

Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV.

Item
http://www.wikidata.org/entity/Q38686803
Recent developments in the diagnosis and management of tuberculosis.Identifying components for programmatic latent tuberculosis infection control in the European Union.Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.[Latent tuberculosis infection in persons with HIV/AIDS, associated factors, and progression to active disease in a city in southern Brazil].Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?
P2860

Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV.

Item
http://www.wikidata.org/entity/Q38686803
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Continuous isoniazid for the t ...... ion in people living with HIV.
@en
type
label
Continuous isoniazid for the t ...... ion in people living with HIV.
@en
prefLabel
Continuous isoniazid for the t ...... ion in people living with HIV.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Continuous isoniazid for the t ...... ion in people living with HIV.
@en
P2093
P2860
P304
P31
P356
10.1097/QAD.0000000000000985
P407
P433
P478
P577
P698
P932